Genertec Universal Medical Group Company Limited (5UM) — Capital Reinvestment Ratio
Genertec Universal Medical Group Company Limited (5UM) has a Capital Reinvestment Ratio of 0.10x as of December 2022, meaning it reinvests 0% of its operating cash flow (€1.69 Billion) in capital expenditures (€170.49 Million). See 5UM cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genertec Universal Medical Group Company Limited Capital Reinvestment Ratio (2022–2025)
This chart tracks Genertec Universal Medical Group Company Limited's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Genertec Universal Medical Group Company Limited (2022–2025)
Year-by-year Capital Reinvestment Ratio for Genertec Universal Medical Group Company Limited from 2022 to 2025. For live market cap and broader valuation context, see Genertec Universal Medical Group Company (5UM) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | €5.78 Billion | €988.91 Million | ▼ -84.5% |
| 2024 | 1.10x | €1.14 Billion | €1.26 Billion | ▲ +514.0% |
| 2023 | 0.18x | €4.99 Billion | €896.83 Million | ▼ -39.2% |
| 2022 | 0.30x | €2.06 Billion | €608.09 Million | — |